Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Women are increasingly engaging in stock market investing. Learn how to build your wealth and navigate the stock market confidently.
28,657 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
NVIDIA is set to report quarterly results as investors wrestle with hype around AI. Analysts forecast strong growth b...
When one tech giant climbs and another stumbles, the market often stays coldsweat steady. Learn how Micron’s strength...
Enrollment gaps in the Trump Accounts program threaten broad access to savings for millions of children, as officials...
GM and Ford are expanding into battery storage, boosting competition for Tesla and signaling a broader shift in how a...
The quantum computing space just crossed a major milestone with its first traditional IPO. This guide breaks down wha...
A leading economist argues that the stock market has drifted away from the pace of everyday economic activity as grow...
Investors watched Alphabet slide as news of AI talent exits raised questions about leadership and the pace of AI inve...
As March unfolds, the stock market today, march narrative centers on margins, capex trends, and AI-driven demand. Thi...
Rising private valuations for SpaceX are fueling chatter about a Tesla takeover. Market participants say the odds spa...
The SpaceX sell-off is showing signs of worsening momentum, but patient investors can still navigate it with a discip...
Mega-IPOs grab headlines, but what sticks after the first week? This article breaks down the five biggest IPOs in his...